Magda Stumpfova
30 works · 792 citations · h-index 4
Top works
- A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors
- Identification of epidermal progenitors for the Merkel cell lineage
- The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
- Zeroing in on ROS1 Rearrangements in Non–Small Cell Lung Cancer
- Identification of epidermal progenitors for the Merkel cell lineage
- Supplementary Table 1 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
- Data from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
- Supplementary Table 1 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
- Supplementary Figure 1 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
- Supplementary Materials and Methods from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
- Supplementary Figure 1 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
- Supplementary Figure 3 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
- Supplementary Figure 2 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
- Data from Zeroing in on ROS1 Rearrangements in Non–Small Cell Lung Cancer
- Supplementary Figures 1-4 from A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors
- Supplementary Figure 4 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
- Supplementary Figure 3 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
- Supplementary Figure Legends 1-4 from The Immunosuppressive Surface Ligand CD200 Augments the Metastatic Capacity of Squamous Cell Carcinoma
- Related Article from Zeroing in on ROS1 Rearrangements in Non–Small Cell Lung Cancer
- Data from A Novel ALK Secondary Mutation and EGFR Signaling Cause Resistance to ALK Kinase Inhibitors